Antiphospholipid antibodies as a potential factor of tumor progression
Introduction. Current generally accepted clinical and laboratory criteria for antiphospholipid syndrome (APS) have been clearly determined, which include vascular thrombosis and pregnancy complications in patients with circulating antiphospholipid antibodies (aPLs). However, in the last several year...
Saved in:
| Main Authors: | Z. D. Aslanova, J. Kh. Khizroeva, A. G. Solopova, V. O. Bitsadze, A. V. Vorobev, J.-C. Gris, I. Elalamy, N. A. Makatsariya, D. Yu. Zabolotnaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2024-03-01
|
| Series: | Акушерство, гинекология и репродукция |
| Subjects: | |
| Online Access: | https://www.gynecology.su/jour/article/view/1890 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extra criterial antiphospholipid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus (preliminary data)
by: F. A. Cheldieva, et al.
Published: (2021-10-01) -
Plasmapheresis for lowering the risks of placenta-associated complications in antiphospholipid syndrome
by: N. F. Kuneshko, et al.
Published: (2025-03-01) -
Detection frequency and duration of circulating antiphospholipid syndrome markers in patients with verified COVID-19
by: Yu. V. Mikhailova, et al.
Published: (2024-05-01) -
Detection of antibodies associated with anti-phospholipid syndrome in patients with syphilis
by: N. K. Levchik, et al.
Published: (2023-04-01) -
Assessment of antiphospholipid antibodies using enzyme-linked immunosorbent assay and chemiluminescent method
by: T. M. Reshetnyak, et al.
Published: (2025-04-01)